GSDMD-Mediated Cardiomyocyte Pyroptosis Promotes Myocardial I/R Injury
Huairui Shi,Yang Gao,Zhen Dong,Ji’e Yang,Rifeng Gao,Xiao Li,Shuqi Zhang,Leilei Ma,Xiaolei Sun,Zeng Wang,Feng Zhang,Kai Hu,Aijun Sun,Junbo Ge,Huairui Shi Yang Gao Zhen Dong Ji'e Yang Rifeng Gao Xiao Li Shuqi Zhang Leilei Ma Xiaolei Sun Zeng Wang Feng Zhang Kai Hu Aijun Sun Junbo Ge Cardiology,Shanghai Institute of Cardiovascular Diseases,Zhongshan Hospital,Fudan University,CHINA Cardiology,Shanghai Institute of Cardiovascular Diseases,Zhongshan Hospital,Fudan University Shanghai Institue of Cardiovascular Disease,Zhongshan Hospital,Fudan University,CHINA Cardiovascular Surgery,The Second Affiliated Hospital of Nanchang University Institute of Biomedical Science,Fudan University,CHINA
DOI: https://doi.org/10.1161/circresaha.120.318629
IF: 23.213
2021-05-22
Circulation Research
Abstract:Rationale: Pyroptosis is a morphologically and mechanistically distinct form of cell death and is characterized by gasdermin D (GSDMD) or gasdermin E (GSDME)-mediated necrosis with excessive inflammatory factor release. Cardiomyocyte necrosis and inflammation play key roles in the pathophysiology of myocardial ischemia/reperfusion (I/R) injury. However, whether cardiomyocytes undergo pyroptosis and the underlying mechanism in myocardial I/R injury remain unclear. Objective: We aimed to investigate the role of pyroptosis in myocardial I/R injury. Methods and Results: In vivo and in vitro experiments were used to investigate pyroptosis of cardiomyocyte and the associated mechanisms during I/R injury. Wild-type (WT), Myh6-Cre and cardiomyocyte-specific GSDMD-deficient (GSDMD-CKO) male mice were subjected to I/R. Human peripheral blood samples were collected from STEMI (acute ST-segment-elevation myocardial infarction) patients or control patients at 0, 1 and 24 h after PCI (percutaneous coronary intervention) in our department. The serum levels of GSDMD were measured by ELISA. H/R (hypoxia/reoxygenation) induced cardiomyocyte pyroptosis and the release of mature IL-18 but not IL-1β, which mechanistically resulted from GSDMD cleavage by caspase-11 in cardiomyocytes. Furthermore, GSDMD gene deletion blocked H/R-induced cardiomyocyte pyroptosis and IL-18 release. GSDMD and its pyroptosis-inducing N-terminal fragment (GSDMD-N) were upregulated in myocardial tissues after I/R injury. Immunofluorescence analysis showed that GSDMD was mainly localized in cardiomyocytes. GSDMD deficiency in cardiomyocytes significantly reduced the I/R-induced myocardial infarct size. Moreover, increased GSDMD serum levels were detected in patients exhibiting I/R injury 1 h after PCI for STEMI. Conclusions: Our results show that GSDMD-mediated cardiomyocyte pyroptosis is a key event during myocardial I/R injury and that the caspase-11/GSDMD pathway may be essential to this process. Additionally, GSDMD inhibition significantly reduces cardiomyocyte pyroptosis and I/R-induced myocardial injury.
cardiac & cardiovascular systems,peripheral vascular disease,hematology